Although the final amount of different subtypes of lymphocytes varied slightly, all the BCG substrains tested gave rise to the upregulation of CD56 on NK cells (Figure 3A, right panel) and increased degranulation against bladder cancer cells (Figure 3B). Here, NCAM1 is linked to urinary bladder cancer.